Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder

Journal of Psychiatric Practice

Volumn 14, Issue 3, 2008, Pages 160-169

  MacMillan, Carlene M ^a,b   Withney, Jane E ^a   Korndörfer, Sergio R ^a,b   Tilley, Claire A ^a   Mrakotsky, Christine ^a,b   Gonzalez Heydrich, Joseph M ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adolescents; Atypical antipsychotics; Bipolar disorder; Children; Divalproex; Pediatric patients; Risperidone

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BUSPIRONE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CITALOPRAM; CLONIDINE; DEXAMPHETAMINE; ETIRACETAM; FLUOXETINE; GABAPENTIN; GUANFACINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; METHYLPHENIDATE; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; OXCARBAZEPINE; RISPERIDONE; SERTRALINE; TRAZODONE; VALPROATE SEMISODIUM;

ADOLESCENT; ARTICLE; BIPOLAR DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; COORDINATION DISORDER; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HYPERSALIVATION; MALE; MEDICAL RECORD; MONOTHERAPY; OUTCOME ASSESSMENT; OUTPATIENT; REGRESSION ANALYSIS; SEIZURE; SIDE EFFECT; SLEEP DISORDER; TREATMENT RESPONSE; WEIGHT GAIN;

ADOLESCENT; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; MALE; PERSONALITY ASSESSMENT; RETROSPECTIVE STUDIES; RISPERIDONE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 44649181125     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000320115.38434.16     Document Type: Article

References (30)

1. World Health Organization. Investing in mental health. Geneva: World Health Organization; 2003 (available at www.who.int/mental_health/media/ investing_mnh.pdf, accessed August 21, 2006).
2. Chang KD, Ketter TA. Special issues in the treatment of pediatric bipolar disorder. Expert Opin Pharmacother 2001;2:613-22.
3. Wozniak J. Recognizing and managing bipolar disorder in children. J Clin Psychiatry 2005;66 (suppl 1):18-23.
4. Biederman J, Faraone SV, Wozniak J, et al. Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. J Psychiatr Res 2005;39:611-22.
5. Faedda GL, Baldessarini RJ, Glovinsky IP, et al. Pediatric bipolar disorder: Phenomenology and course of illness. Bipolar Disord 2004;6:305-13.
6. Biederman J, Mick E, Wozniak J, et al. An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2005;15:311-7.
7. Kowatch RA, Fristad M, Birmaher B, et al. Treatment guidelines for children and adolescent with bipolar disorder: Child psychiatry workgroup on bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005;44:213-35.
8. Masi G. Prepubertal bipolar disorder: Available pharmacological treatment options. Expert Opin Pharmacother 2005;6:547-60.
9. Biederman J, Mick E, Faraone SV, et al. A prospective follow-up study of pediatric bipolar disorder in boys with attention-deficit/hyperactivity disorder. J Affect Disord 2004;82(suppl 1):S17-S23.
10. Jairam R, Srinath S, Girimaji SC, et al. A prospective 4-5 year follow-up of juvenile onset bipolar disorder. Bipolar Disord 2004;6:386-94.
11. Keck PE Jr. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania. J Clin Psychiatry 2005;66(suppl 3):5-11.
12. Findling RL. Update on the treatment of bipolar disorder in children and adolescents. Eur Psychiatry 2005;20:87-91.
13. Danielyan A, Kowatch RA. Management options for bipolar disorder in children and adolescents. Paediatr Drugs 2005;7:277-94.
14. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-24.
15. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. 2002. Am J Psychiatry 2002;159(4 suppl):1-50.
16. Wagner KD, Weller EB, Carlson GA, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002;41:1224-30.
17. Henry CA, Zamvil LS, Lam C, et al. Long-term outcome with divalproex in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2003;13:523-9.
18. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39:713-20.
19. An outpatient study of the effectiveness and safety of depakote ER in the treatment of mania/bipolar disorder in children and adolescents. (Clinical Trials.gov Identifier NCT00067262; can be accessed at http://clinicaltrials.gov/ ct2/show/NCT00067262?term=NCT00067262&rank=1).
20. FDA approved Risperdal for two psychiatric conditions in children and adolescents. FDA News, August 22, 2007. www.fda.gov/bbs/topics/NEWS/2007/ NEW01686.html
21. Tohen M, Baker RW, Altshuler LL, et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002;159:1011-7.
22. DelBello MP, Kowatch RA, Adler CM, et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006:45:305-13.
23. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systemic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry 2007:46:687-700.
24. Gonzalez-Heydrich J, DeMaso DR, Irwin C, et al. Implementation of an electronic medical record system in a pediatric psychopharmacology program. Int J Med Inform 2000;57:109-6.
25. Guy W. ECDEU assessment manual for psychopharmacology-revised (DHEW Publ. No ADM 76-338). Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs 1976:218-22.
26. Green HG. Child and adolescent clinical psychopharmacology. Philadelphia; Lippincott, Williams & Wilkins; 2001.
27. Spencer T, Wilens T, Biederman J. Psychotropic medication for children and adolescents. Child Adolesc Psychiatr Clin N Am 1995;4:97-121.
28. US Department of Health and Human Services. Centers for Disease Control and Prevention, 2005 (available at www.cdc.gov, accessed November 20, 2005).
29. Frazier JA, Meyer MC, Biederman J, et al. Risperidone treatment for juvenile bipolar disorder: A retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999:38:960-5.
30. Pavuluri MN, Henry DB, Calbray JA, et al. Divalproex sodium for pediatric mixed mania: A 6-month prospective trial. Bipolar Disord 2005;7:266-73.